NCT00315835View on ClinicalTrials.gov

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 31, 1996

Study Completion Date

November 30, 1997

Conditions

Postoperative Pain

Interventions

DRUG

Buprenorphine transdermal delivery system

Trial Locations (1)

33324

Park Place Therapeutic Center, Plantation

All Listed Sponsors

lead

Purdue Pharma LP

INDUSTRY